Hypera S.A.  logo

Hypera S.A. Investor Relations Material

Hypera S.A. operates as a pharmaceutical company in Brazil. The company is involved in the production, research and development, marketing, sale and distribution of medicinal products for the treatment of various diseases such as diabetes, asthma, epilepsy and other disorders. Hypera S.A. engages through Pharmaceuticals and Biotechnologies segments. The Pharmaceuticals segment promotes and sells hyperbaric oxygen therapy (HOT) chambers to treat burns; Cortical Stimulation Therapy (CST); foot orthoses; jogging rollers; heart valves, pacemakers and implantable cardioverter defibrillator; the pregnancy test kit, pregnancy urine test kit and ovulation predictors; and iron supplements.

Upcoming events for

Q3 20222022-10-31
Q2 20222022-08-01

Latest company events

More about Hypera S.A.

Ticker symbol

HYPE3

Country

Brazil

Investor Relations Page

https://ri.hypera.com.br/en/

Dig deeper into the Hypera S.A. fundamentals on Quartr.

  • Skip straight to the Q&A session
  • Receive notifications about new events
  • Connect the financial calender on your phone
  • Figure out why the stock is up or down
  • Read the transcripts or scroll the deck
  • Access earnings or press releases
App store link
Android play link
Quartr app screenshot